Palbociclib in metastatic breast cancer: current evidence and real-life data

• Principais autores: Francesco Serra (Autor), Pietro Lapidari (Autor), Erica Quaquarini (Autor), Barbara Tagliaferri (Autor), Federico Sottotetti (Autor), Raffaella Palumbo (Autor)
• Formato: Livro
• Publicado em: BioExcel Publishing Ltd, 2019-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The purpose of this review is to summarize the background and latest evidence for the use of palbociclib, an oral, first-in-class, highly selective cyclin-dependent kinase 4/6 inhibitor, in advanced breast cancer, with a focus on some of the unanswered questions about the performance of this agent i...